chemoprevention – Medxy AI

New 2026 Multisociety Guidelines for Atypical Breast Lesions and LCIS: What Clinicians Need to Know

By MedXY 08/21/2026

Multisociety 2026 guidance clarifies diagnosis and management of atypical breast lesions and lobular carcinoma in situ, balancing excision, surveillance, and chemoprevention based on lesion type, radiologic concordance, and risk.

Clinical Updates Gastroenterology Specialties

Berberine Demonstrates Long-Term Prevention of Colorectal Adenoma Recurrence: A Six-Year Follow-Up Study

By MedXY 08/23/2025

Berberine shows sustained efficacy and safety in reducing colorectal adenoma recurrence and neoplasm occurrence after polypectomy, providing new directions for secondary prevention of colorectal cancer.

Clinical Updates Family Medicine & Nutrition news Public Health Specialties

Seasonal Malaria Chemoprevention in Uganda: Efficacy of SPAQ and Dihydroartemisinin-Piperaquine in the Era of Drug Resistance

By MedXY 08/03/2025

A large cluster-randomised trial in Uganda demonstrates that both SPAQ and dihydroartemisinin-piperaquine are highly effective and safe for seasonal malaria chemoprevention in children, with no evidence of resistance selection.